The recently enacted Medication Access and Training Expansion (MATE) Act, requires that Drug Enforcement Administration (DEA)-registered health care providers (except those in exclusive veterinary practice) complete training on the treatment and management of opioid or other substance use disorders. This mandated eight (8) hours of education is a one-time requirement and can be fulfilled using one or more continuing education (CE) activities related to opioid and other substance use. Evidence of completed education will be requested after June 27, 2023 whenever a provider applies for a new or renewed DEA registration to be a licensed prescriber of controlled substances.

AKH’s Substance Use Disorder Accredited Education is designed to meet the educational requirements as outlined in the MATE Act. Four (4) individual, accredited CE activities are available. These text-based monographs can be purchased individually or as a 4-activity package.

Target Audience

All Drug Enforcement Administration (DEA)-registered practitioners* who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.

*For more information about practitioners who have satisfied this requirement, click here.

Recent courses

  • Enduring Material
Activity 1 – Defining and Managing Pain
  • Pain Management
  • DEA Mate Act
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act.
0
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 AAPA Category 1 CME
    • 2.00 AANP
      • 1.50 AANP Pharmacology Contact Hours
    • 2.00 ADA CERP
    • 2.00 Attendance
  • Enduring Material
Activity 2 – Identifying and Managing Patients with Substance Use Disorder (SUD)
  • Pain Management
  • DEA Mate Act
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act.
0
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 AAPA Category 1 CME
    • 2.00 AANP
      • 1.50 AANP Pharmacology Contact Hours
    • 2.00 ADA CERP
    • 2.00 Attendance
  • Enduring Material
Activity 3 – Safe and Effective Pain Management Utilizing Opioid Therapy
  • Pain Management
  • DEA Mate Act
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act.
0
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 AAPA Category 1 CME
    • 2.00 AANP
      • 0.00 AANP Pharmacology Contact Hours
    • 2.00 ADA CERP
    • 2.00 Attendance
  • Enduring Material
Activity 4 – Overcoming Barriers in the Management of Patients with Opioid Use Disorder (OUD)
  • Pain Management
  • DEA Mate Act
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act.
0
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 AAPA Category 1 CME
    • 2.00 AANP
      • 0.00 AANP Pharmacology Contact Hours
    • 2.00 ADA CERP
    • 2.00 Attendance
  • Enduring Material
DEA MATE Act Substance Use Disorder 4-Activity Package
  • Pain Management
  • DEA Mate Act
The recently enacted Medication Access and Training Expansion (MATE) Act, requires that Drug Enforcement Administration (DEA)-registered health care providers (except those in exclusive veterinary
0
    • 8.00 AMA PRA Category 1 Credit™
    • 8.00 AAPA Category 1 CME
    • 8.00 AANP
      • 3.00 AANP Pharmacology Contact Hours
    • 8.00 ADA CERP
    • 8.00 Attendance